245 related articles for article (PubMed ID: 18523999)
1. Predicting disease progression after nephrectomy for localized renal cell carcinoma: the utility of prognostic models and molecular biomarkers.
Crispen PL; Boorjian SA; Lohse CM; Leibovich BC; Kwon ED
Cancer; 2008 Aug; 113(3):450-60. PubMed ID: 18523999
[TBL] [Abstract][Full Text] [Related]
2. A Multigene Signature Based on Cell Cycle Proliferation Improves Prediction of Mortality Within 5 Yr of Radical Nephrectomy for Renal Cell Carcinoma.
Morgan TM; Mehra R; Tiemeny P; Wolf JS; Wu S; Sangale Z; Brawer M; Stone S; Wu CL; Feldman AS
Eur Urol; 2018 May; 73(5):763-769. PubMed ID: 29249291
[TBL] [Abstract][Full Text] [Related]
3. Prognostic models and algorithms in renal cell carcinoma.
Lane BR; Kattan MW
Urol Clin North Am; 2008 Nov; 35(4):613-25; vii. PubMed ID: 18992615
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-15a tissue expression is a prognostic marker for survival in patients with clear cell renal cell carcinoma.
Mytsyk Y; Borys Y; Tumanovska L; Stroy D; Kucher A; Gazdikova K; Rodrigo L; Kruzliak P; Prosecky R; Urdzik P; Dosenko V
Clin Exp Med; 2019 Nov; 19(4):515-524. PubMed ID: 31440867
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNAs enable precise diagnosis and prediction of early relapse after nephrectomy in patients with renal cell carcinoma.
Bohosova J; Kozelkova K; Al Tukmachi D; Trachtova K; Naar O; Ruckova M; Kolarikova E; Stanik M; Poprach A; Slaby O
J Cancer Res Clin Oncol; 2023 Aug; 149(10):7587-7600. PubMed ID: 36988708
[TBL] [Abstract][Full Text] [Related]
6. The role of adjuvant immunotherapy after radical nephrectomy and prognostic factors in pT3N0M0 renal cell carcinoma.
Jeon SH; Chang SG; Kim JI
Anticancer Res; 1999; 19(6C):5593-7. PubMed ID: 10697624
[TBL] [Abstract][Full Text] [Related]
7. Creation of a primary tumor tissue expression biomarker-augmented prognostic model for patients with metastatic renal cell carcinoma.
Bearrick EN; Packiam V; Bhindi B; Lohse CM; Cheville JC; Mason RJ; Tollefson M; Harrington S; Dong H; Parker AS; Boorjian SA; Thompson RH; Leibovich BC
Urol Oncol; 2021 Feb; 39(2):135.e1-135.e8. PubMed ID: 33309297
[TBL] [Abstract][Full Text] [Related]
8. Expression of epithelial-mesenchymal transition markers in renal cell carcinoma: impact on prognostic outcomes in patients undergoing radical nephrectomy.
Harada K; Miyake H; Kusuda Y; Fujisawa M
BJU Int; 2012 Dec; 110(11 Pt C):E1131-7. PubMed ID: 22712620
[TBL] [Abstract][Full Text] [Related]
9. p53-expression in patients with renal cell carcinoma correlates with a higher probability of disease progression and increased cancer-specific mortality after surgery but does not enhance the predictive accuracy of robust outcome models.
Morshaeuser L; May M; Burger M; Otto W; Hutterer GC; Pichler M; Klatte T; Wild P; Buser L; Brookman-May S
Urol Oncol; 2018 Mar; 36(3):94.e15-94.e21. PubMed ID: 29221641
[TBL] [Abstract][Full Text] [Related]
10. The Association Between Small Primary Tumor Size and Prognosis in Metastatic Renal Cell Carcinoma: Insights from Two Independent Cohorts of Patients Who Underwent Cytoreductive Nephrectomy.
DiNatale RG; Xie W; Becerra MF; Silagy AW; Attalla K; Sanchez A; Mano R; Marcon J; Blum KA; Benfante NE; Voss MH; Motzer RJ; Coleman J; Choueiri TK; Reznik E; Russo P; Heng DYC; Hakimi AA
Eur Urol Oncol; 2020 Feb; 3(1):47-56. PubMed ID: 31735646
[TBL] [Abstract][Full Text] [Related]
11. Guideline of guidelines: follow-up after nephrectomy for renal cell carcinoma.
Williamson TJ; Pearson JR; Ischia J; Bolton DM; Lawrentschuk N
BJU Int; 2016 Apr; 117(4):555-62. PubMed ID: 26617405
[TBL] [Abstract][Full Text] [Related]
12. CXC chemokine receptor 2 is associated with postoperative recurrence and survival of patients with non-metastatic clear-cell renal cell carcinoma.
An H; Xu L; Chang Y; Zhu Y; Yang Y; Chen L; Lin Z; Xu J
Eur J Cancer; 2015 Sep; 51(14):1953-61. PubMed ID: 26188847
[TBL] [Abstract][Full Text] [Related]
13. Transcriptomics in RCC.
Syed JS; Brito J; Pooli A; Boutros PC; Shuch B
Urol Oncol; 2020 Oct; 38(10):742-754. PubMed ID: 32222350
[TBL] [Abstract][Full Text] [Related]
14. A risk stratification model based on four novel biomarkers predicts prognosis for patients with renal cell carcinoma.
Kubota S; Yoshida T; Kageyama S; Isono T; Yuasa T; Yonese J; Kushima R; Kawauchi A; Chano T
World J Surg Oncol; 2020 Oct; 18(1):270. PubMed ID: 33092599
[TBL] [Abstract][Full Text] [Related]
15. Validation of a Postoperative Nomogram Predicting Recurrence in Patients with Conventional Clear Cell Renal Cell Carcinoma.
Lee BH; Feifer A; Feuerstein MA; Benfante NE; Kou L; Yu C; Kattan MW; Russo P
Eur Urol Focus; 2018 Jan; 4(1):100-105. PubMed ID: 28753780
[TBL] [Abstract][Full Text] [Related]
16. BioScore (B7-H1, survivin, and Ki-67) does not predict cancer-specific mortality in surgically treated patients with renal cell carcinoma: An external validation study.
Hutterer GC; Posch F; Buser L; Zigeuner R; Morshäuser L; Otto W; Wild PJ; Burger M; May M; Pichler M; Brookman-May SD
Urol Oncol; 2019 Jul; 37(7):510-518. PubMed ID: 31060796
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic and prognostic accuracy of miR-21 in renal cell carcinoma: a systematic review protocol.
Rasti A; Mehrazma M; Madjd Z; Keshtkar AA; Roudi R; Babashah S
BMJ Open; 2016 Jan; 6(1):e009667. PubMed ID: 26729387
[TBL] [Abstract][Full Text] [Related]
18. CCL2/CCR2 axis is associated with postoperative survival and recurrence of patients with non-metastatic clear-cell renal cell carcinoma.
Wang Z; Xie H; Zhou L; Liu Z; Fu H; Zhu Y; Xu L; Xu J
Oncotarget; 2016 Aug; 7(32):51525-51534. PubMed ID: 27409666
[TBL] [Abstract][Full Text] [Related]
19. Mutations in renal cell carcinoma.
D'Avella C; Abbosh P; Pal SK; Geynisman DM
Urol Oncol; 2020 Oct; 38(10):763-773. PubMed ID: 30478013
[TBL] [Abstract][Full Text] [Related]
20. Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).
Brookman-May S; May M; Shariat SF; Xylinas E; Stief C; Zigeuner R; Chromecki T; Burger M; Wieland WF; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Feciche B; Truss M; Gilfrich C; Pahernik S; Hohenfellner M; Zastrow S; Wirth MP; Novara G; Carini M; Minervini A; Simeone C; Antonelli A; Mirone V; Longo N; Simonato A; Carmignani G; Ficarra V;
Eur Urol; 2013 Sep; 64(3):472-7. PubMed ID: 22748912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
